How Does AI Augment Predictive Cancer Research and Diagnosis?
Mateusz Tylicki, BSc
Deep learning and AI-based decisions are becoming increasingly reliable but remain far from being adapted to cancer diagnostics
Molecular Diagnostics
U.S. FDA Proposed Rule on Laboratory-Developed Tests
Erica Conway, PhD
The FDA faces a quandary—increasing oversight of LDTs to protect public health without affecting the quality of patient care
Noninvasive Fetal Screening Effectively Detects Abnormalities
Massachusetts General Hospital
Noninvasive method has the potential to survey the entire fetal exome without the need for amniocentesis
FDA Proposed Rule on LDT Regulation: Comments Due Soon
Shannon Bennett, MS, MBA
Clinical laboratories should strongly consider submitting comments before the Dec. 4 deadline
MS Biomarker Test Gets Breakthrough Device Designation
Swathi Kodaikal, MSc
Blood NfL levels can provide insights into neurological conditions such as Alzheimer’s, Parkison’s, and Huntington’s diseases
How NGS-Based Testing Can Advance Reproductive Health Research
Kathy Davy, MBA
High throughput, reliability, sensitivity, and accuracy make NGS a robust reproductive health tool
World’s Fastest COVID-19 Test Is Here!
University of Bath
Compact, lab-on-a-chip genetic testing device detects SARS-CoV-2 in nasal swab samples within minutes
Progress in Precision Oncology: AACR Cancer Progress Report 2023
Michael Schubert, PhD
Liquid biopsy, molecular profiling, and other recent advances from the AACR Cancer Progress Report 2023
How Can Diverse Genomic Approaches Improve Rare Disease Research?
Tomi Pastinen, MD, PhD
Multiomic techniques can robustly screen and identify often-missed genetic determinants of rare diseases
Blood Test to Detect Cancer Early in High-Risk Families
The Hospital for Sick Children
Liquid biopsies help extract and screen circulating tumor DNA for cancer-causing anomalies well in advance
New Hepatitis E, Diabetes Tests Included in WHO’s Essential Diagnostics Lists
World Health Organization
EDLs will help countries develop national and international IVD policies to deliver better patient care
Research and the Future of Clinical Diagnostics
Laura Prescott, MS, Andrew Gane
An inside look at the next few years of clinical diagnostics
AMP Releases Liquid Biopsy Assay Validation Recommendations
Association for Molecular Pathology
New joint consensus manuscript from AMP developed in collaboration with ASCO and CAP
Can Phage-Based Diagnostics End the Global TB Rage?
Jane Theaker, MSc
Natural mechanisms of bacteriophages may help identify active TB early in those at risk
Ultrasensitive Blood Test Detects Multi-Cancer-Specific Biomarker
Mass General Brigham
Novel blood test detects the highly specific ORF1p biomarker found in multiple cancers
Ensuring Specimen Integrity Is Everyone’s Job
Emily Berlin, BS, MBA
Delivering high-quality patient care heavily relies on eliminating medical errors and maintaining specimen integrity
Leveraging Next-Gen IHC Tools to Advance Precision Oncology Research
Swathi Kodaikal, MSc
Harnessing the power of multiplexing and RNA–protein studies could help design targeted cancer treatments
Portable Device Enables Rapid On-Site Detection of SARS-CoV-2
American Society for Microbiology
The device helps detect SARS-CoV-2 at points of care and in areas with barriers to health care
Novel AI-Based Predictive Tool May Accelerate Drug Discovery
Texas Children's Hospital Jan and Dan Duncan Neurological Research Institute
The tool “learns” from existing gene-gene or gene-drug interactions and predicts novel relationships
FDA Authorizes First Genetic Test to Assess Risk of Multiple Cancers
U.S. Food and Drug Administration
The new prescription test doesn’t identify or evaluate all known genes that may predispose an individual to cancer